Bionano Genomics (BNGO) Gross Profit (2017 - 2026)

Bionano Genomics' Gross Profit history runs 10 years deep, the most recent figure standing at $3.3 million for Q1 2026.

• In Q1 2026, Gross Profit rose 10.69% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $13.5 million (up 165.55% YoY), while the FY2025 annual figure was $13.2 million, up 3369.74% from the prior year.
• Gross Profit came in at $3.3 million for Q1 2026 at Bionano Genomics, down from $3.4 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $8.0 million in Q4 2024 to a low of -$8.4 million in Q3 2024.
• A 5-year average of $2.2 million and a median of $2.6 million in 2024 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit surged 655.23% in 2022 and tumbled 407.24% in 2024, its largest moves.
• Bionano Genomics' Gross Profit stood at $1.8 million in 2022, then surged by 35.07% to $2.4 million in 2023, then jumped by 228.38% to $8.0 million in 2024, then sank by 57.54% to $3.4 million in 2025, then fell by 4.32% to $3.3 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $3.3 million, $3.4 million, and $3.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison